Showing results (1201-1210 of 1,211) with videos related to

Sort By:
Pageof 122
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2022
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancerK Van Baelen, T Geukens, M Maetens, et al.
British Journal of Cancer|April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trialC Le Tourneau, X Paoletti, N Servant, et al.
Annals of Surgery|April 28, 2025
Frailty and Survival for Diagnoses Feasibly Managed Operatively or NonoperativelyEmily Mosher, Hasan Nassereldine, Jeffrey C McKibben, et al.
JAMA Surgery|November 14, 2019
Association of Preoperative Patient Frailty and Operative Stress With Postoperative MortalityMyrick C Shinall, Shipra Arya, Ada Youk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP Tarantino, G Viale, M F Press, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classificationK Rahmani Narj Abadi, C Dupain, I Guillou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2025
Clinical challenges and proposed solutions for patients with invasive lobular breast cancerK Van Baelen, E Sawyer, J Van Cauwenberge, et al.
The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survivalY Wang, D Drubay, S F Jonas, et al.
Communications Biology|August 4, 2025
fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experienceMeryem A Yücel, Robert Luke, Rickson C Mesquita, et al.
Pageof 122